DownloadHi-Res Photo

Roger J. Jou

MD, PhD, MPH

Instructor of Clinical Child Psychiatry

Research & Publications
Biography
News

Coauthors

Selected Publications

Diffusion Tensor Magnetic Resonance ImagingJou R, Staib L. Diffusion Tensor Magnetic Resonance Imaging 2021, 1459-1468. DOI: 10.1007/978-3-319-91280-6_554.
Magnetic Resonance ImagingMateljevic N, Jou R. Magnetic Resonance Imaging 2021, 2785-2789. DOI: 10.1007/978-3-319-91280-6_565.
Cerebellar Abnormalities in AutismHardan A, Jou R. Cerebellar Abnormalities in Autism 2021, 853-858. DOI: 10.1007/978-3-319-91280-6_663.
CerebellumHardan A, Jou R. Cerebellum 2021, 859-859. DOI: 10.1007/978-3-319-91280-6_664.
A PHASE 2 RANDOMIZED CONTROLLED TRIAL OF BALOVAPTAN IN PEDIATRIC PARTICIPANTS WITH AUTISM SPECTRUM DISORDERHollander E, Jacob S, Jou R, McNamara N, Sikich L, Tobe R, Smith J, Sanders K, Squassante L, Murtagh L, Gleissl T, Wandel C, Veenstra-VanderWeele J. A PHASE 2 RANDOMIZED CONTROLLED TRIAL OF BALOVAPTAN IN PEDIATRIC PARTICIPANTS WITH AUTISM SPECTRUM DISORDER Journal Of The American Academy Of Child & Adolescent Psychiatry 2020, 59: s262-s263. DOI: 10.1016/j.jaac.2020.08.458.
1.3 Abnormal Neural Connectivity in Girls but Not Boys with Autism: A Group-Matched, Quality-Controlled, Diffusion Tensor Imaging StudyJou R, Lei J, Lecarie E, Yang D, Ventola P, Sukhodolsky D, Pelphrey K. 1.3 Abnormal Neural Connectivity in Girls but Not Boys with Autism: A Group-Matched, Quality-Controlled, Diffusion Tensor Imaging Study Journal Of The American Academy Of Child & Adolescent Psychiatry 2017, 56: s152-s153. DOI: 10.1016/j.jaac.2017.09.017.
P.7.d.011 Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorderDel Valle Rubido M, Umbricht D, Shic F, McCracken J, Scahill L, Khwaja O, Squassante L, Boak L, Bolognani F, Fontoura P, Wall C, Jou R, Loomis R, Lyons M, Gavaletz A, Cowen J, Apelian T, Jeste S, Ferretti C, Taylor B, Berlin G, Noone R, Antar L, Hollander E. P.7.d.011 Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder European Neuropsychopharmacology 2015, 25: s646-s647. DOI: 10.1016/s0924-977x(15)30917-2.
Quetiapine in children and adolescents with subaverage IQJou R, Handen B, Hardan A. Quetiapine in children and adolescents with subaverage IQ Journal Of Pediatric Neurology 2015, 03: 035-039. DOI: 10.1055/s-0035-1557235.
A two-year longitudinal pilot MRI study of the brainstem in autismJou RJ, Frazier TW, Keshavan MS, Minshew NJ, Hardan AY. A two-year longitudinal pilot MRI study of the brainstem in autism Behavioural Brain Research 2013, 251: 163-167. PMID: 23619132, PMCID: PMC4107420, DOI: 10.1016/j.bbr.2013.04.021.
Cerebellar Abnormalities in AutismHardan A, Jou R. Cerebellar Abnormalities in Autism 2013, 553-559. DOI: 10.1007/978-1-4419-1698-3_663.
CerebellumHardan A, Jou R. Cerebellum 2013, 559-560. DOI: 10.1007/978-1-4419-1698-3_664.
Diffusion Tensor Magnetic Resonance ImagingJou R, Staib L. Diffusion Tensor Magnetic Resonance Imaging 2013, 966-975. DOI: 10.1007/978-1-4419-1698-3_554.
Magnetic Resonance ImagingMateljevic N, Jou R. Magnetic Resonance Imaging 2013, 1779-1783. DOI: 10.1007/978-1-4419-1698-3_565.
Structural Neural Phenotype of Autism: Preliminary Evidence from a Diffusion Tensor Imaging Study Using Tract-Based Spatial StatisticsJou RJ, Mateljevic N, Kaiser MD, Sugrue DR, Volkmar FR, Pelphrey KA. Structural Neural Phenotype of Autism: Preliminary Evidence from a Diffusion Tensor Imaging Study Using Tract-Based Spatial Statistics American Journal Of Neuroradiology 2011, 32: 1607-1613. PMID: 21799040, PMCID: PMC7965377, DOI: 10.3174/ajnr.a2558.
Diffusion Tensor Imaging in Autism Spectrum Disorders: Preliminary Evidence of Abnormal Neural ConnectivityJou RJ, Jackowski AP, Papademetris X, Rajeevan N, Staib LH, Volkmar FR. Diffusion Tensor Imaging in Autism Spectrum Disorders: Preliminary Evidence of Abnormal Neural Connectivity Australian & New Zealand Journal Of Psychiatry 2011, 45: 153-162. PMID: 21128874, PMCID: PMC3123660, DOI: 10.3109/00048674.2010.534069.
Reduced central white matter volume in autism: Implications for long‐range connectivityJou RJ, Mateljevic N, Minshew NJ, Keshavan MS, Hardan AY. Reduced central white matter volume in autism: Implications for long‐range connectivity Psychiatry And Clinical Neurosciences 2010, 65: 98-101. PMID: 21265943, PMCID: PMC3114568, DOI: 10.1111/j.1440-1819.2010.02164.x.
Enlarged right superior temporal gyrus in children and adolescents with autismJou RJ, Minshew NJ, Keshavan MS, Vitale MP, Hardan AY. Enlarged right superior temporal gyrus in children and adolescents with autism Brain Research 2010, 1360: 205-212. PMID: 20833154, PMCID: PMC2990401, DOI: 10.1016/j.brainres.2010.09.005.
Cortical Gyrification in Autistic and Asperger Disorders: A Preliminary Magnetic Resonance Imaging StudyJou RJ, Minshew NJ, Keshavan MS, Hardan AY. Cortical Gyrification in Autistic and Asperger Disorders: A Preliminary Magnetic Resonance Imaging Study Journal Of Child Neurology 2010, 25: 1462-1467. PMID: 20413799, PMCID: PMC3115701, DOI: 10.1177/0883073810368311.
Brainstem volumetric alterations in children with autismJou RJ, Minshew NJ, Melhem NM, Keshavan MS, Hardan AY. Brainstem volumetric alterations in children with autism Psychological Medicine 2008, 39: 1347-1354. PMID: 18812009, PMCID: PMC2888007, DOI: 10.1017/s0033291708004376.
Abnormalities in white matter structure in autism spectrum disorders detected by diffusion tensor imagingJou R, Paterson S, Papademetris X, Staib L, Schultz R. Abnormalities in white matter structure in autism spectrum disorders detected by diffusion tensor imaging Neuroscience Research 2007, 58: s62. DOI: 10.1016/j.neures.2007.06.367.
Retrospective Study of Quetiapine in Children and Adolescents with Pervasive Developmental DisordersHardan A, Jou R, Handen B. Retrospective Study of Quetiapine in Children and Adolescents with Pervasive Developmental Disorders Journal Of Autism And Developmental Disorders 2005, 35: 387-391. PMID: 16119479, DOI: 10.1007/s10803-005-3306-1.
Retrospective Assessment of Atomoxetine in Children and Adolescents with Pervasive Developmental DisordersJou R, Handen B, Hardan A. Retrospective Assessment of Atomoxetine in Children and Adolescents with Pervasive Developmental Disorders Journal Of Child And Adolescent Psychopharmacology 2005, 15: 325-330. PMID: 15910217, DOI: 10.1089/cap.2005.15.325.
Reduced cortical folding in individuals at high risk for schizophrenia: a pilot studyJou RJ, Hardan AY, Keshavan MS. Reduced cortical folding in individuals at high risk for schizophrenia: a pilot study Schizophrenia Research 2004, 75: 309-313. PMID: 15885522, DOI: 10.1016/j.schres.2004.11.008.
Psychostimulant treatment of adults with mental retardation and attention‐deficit hyperactivity disorderJou R, Handen B, Hardan A. Psychostimulant treatment of adults with mental retardation and attention‐deficit hyperactivity disorder Australasian Psychiatry 2004, 12: 376-379. DOI: 10.1111/j.1440-1665.2004.02130.x.
Psychostimulant Treatment of Adults With Mental Retardation and Attention-Deficit Hyperactivity DisorderJou R, Handen B, Hardan A. Psychostimulant Treatment of Adults With Mental Retardation and Attention-Deficit Hyperactivity Disorder Australasian Psychiatry 2004, 12: 376-379. PMID: 15715811, DOI: 10.1080/j.1440-1665.2004.02130.x.
Increased frontal cortical folding in autism: a preliminary MRI studyHardan A, Jou R, Keshavan M, Varma R, Minshew N. Increased frontal cortical folding in autism: a preliminary MRI study Psychiatry Research 2004, 131: 263-268. PMID: 15465295, DOI: 10.1016/j.pscychresns.2004.06.001.
A Retrospective Assessment of Topiramate in Children and Adolescents with Pervasive Developmental DisordersHardan A, Jou R, Handen B. A Retrospective Assessment of Topiramate in Children and Adolescents with Pervasive Developmental Disorders Journal Of Child And Adolescent Psychopharmacology 2004, 14: 426-432. PMID: 15650499, DOI: 10.1089/cap.2004.14.426.
Triple diagnosis: dual diagnosis and HIV disease, part 2.Douaihy A, Jou R, Gorske T, Salloum I. Triple diagnosis: dual diagnosis and HIV disease, part 2. The AIDS Reader 2003, 13: 375-82. PMID: 14524322.
Triple diagnosis: dual diagnosis and HIV disease, Part 1.Douaihy A, Jou R, Gorske T, Salloum I. Triple diagnosis: dual diagnosis and HIV disease, Part 1. The AIDS Reader 2003, 13: 331-2, 339-41. PMID: 12889451.

Clinical Trials

Conditions	Study Title
Child Development & Autism; Mental Health & Behavioral Research	AB-2004 in Treatment of Adolescents With Irritability Associated With Autism Spectrum Disorder (ASD)
Child Development & Autism	A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)
Child Development & Autism	SPARK: Simons Foundation Powering Autism Research for Knowledge, a national cohort of individuals and families affected by Autism Spectrum Disorder

Edit Profile

Roger J. Jou

Contact Information

Mailing Address

Related Links

Research & Publications

Biography

News

Coauthors

Selected Publications

Clinical Trials